Inzen Therapeutics is Drug Discovery in United States that focus on machine learning business. They cover business area such as operator, biotechnology company, drug, chronic disease, mass spectrometry, machine learning, novel probe, genetic and chemical biological technology, novel product, cancer, fibrotic disorder, immune-inflammatory disorder, metabolic disorder, degenerative disease, medical health practitioner, treatment, such disease.
-
Machine Learning
-
790 Memorial Drive
Suite 2C
Cambridge, MA 02139
United States
Private
operatorbiotechnology companydrugchronic diseasemass spectrometrymachine learningnovel probegenetic and chemical biological technologynovel productcancerfibrotic disorderimmune-inflammatory disordermetabolic disorderdegenerative diseasemedical health practitionertreatmentsuch disease
* We use standard office opening hours in near Inzen Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Inzen Therapeutics is Drug Discovery business from United States that founded in - ( years old in ), Inzen Therapeutics business is focusing on Machine Learning.
Inzen Therapeutics headquarter office and corporate office address is located in 790 Memorial Drive Suite 2C Cambridge, MA 02139 United States.
Inzen Therapeutics was founded in United States.
In , Inzen Therapeutics is currently focus on machine learning sector.
Above is snippet of Google Trends for "machine learning" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Inzen Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
